Stock Alert for BioSphere Medical Inc. Issued by MicroStockProfit
2010年5月17日 - 6:50PM
MicroStockProfit.com announces an investment report featuring
BioSphere Medical Inc. (Nasdaq:BSMD). The report includes
financial, comparative and investment analyses, and industry
information you need to know to make an educated investment
decision.
The full report is available at:
www.microstockprofit.com/ads/BSMD
BioSphere Medical Inc. (BSMD) develops, markets and manufactures
products for medical procedures, which uses embolotherapy.
Embolotherapy is the minimally invasive, image-guided therapeutic
introduction of various biocompatible substances into a patient's
circulatory system to occlude a blood vessel, either to arrest or
prevent hemorrhaging, or to devitalize or destroy the structure by
occluding its blood supply. The technologies consist of
bioengineered polymers, which are chemical compounds created
through the application of medical science, engineering principles
and manufacturing methods. As of December 31, 2009, the Company
marketed and sold four microsphere products: EmboSphere
Microspheres, EmboGold Microspheres, HepaSphere Microspheres and
QuadraSphere Microspheres.
Message Board Search for BSMD:
http://www.boardcentral.com/boards/BSMD
In the report, the analyst notes:
"Total worldwide revenue for the first quarter of 2010 was $7.12
million, compared with $7.28 million in the first quarter of 2009,
a decline of 2%. Total revenue in the first quarter of this year
includes $0.08 million from Nippon Kayaku, the Company's
distribution partner in Japan.
"BSMD - the pioneer in the use of bioengineered
microspheres to treat uterine fibroids, hypervascularized tumors
and vascular malformations by a minimally invasive, image-guided
medical procedure called embolotherapy - recently reported that it
has entered into an a definitive agreement and plan of merger with
Merit Medical Systems, Inc. and Merit BioAcquisition Co., a wholly
owned subsidiary of Merit Medical pursuant to which BSMD will merge
with and into Merit BioAcquisition Co. in a cash transaction valued
at approximately $96 million."
To read the entire report visit:
www.microstockprofit.com/ads/BSMD
See what investors are saying about BSMD at penny stock
forum
MicroStockProfit.com is a small-cap research and investment
commentary provider. MicroStockProfit.com strives to provide a
balanced view of many promising small-cap companies that would
otherwise fall under the radar of the typical Wall Street investor.
We provide investors with an excellent first step in their research
and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more
information on MicroStockProfit please visit:
http://www.microstockprofit.com.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.com
Brian Johnson
1-888-307-2850
info@microstockprofit.com
Biosphere Medical (MM) (NASDAQ:BSMD)
過去 株価チャート
から 9 2024 まで 10 2024
Biosphere Medical (MM) (NASDAQ:BSMD)
過去 株価チャート
から 10 2023 まで 10 2024